
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis Inc. is set to experience substantial revenue growth, with projections indicating an increase to $43 million in systems revenue and $31 million in disposable revenue by FY26, driven by the adoption of new systems and catheter utilization. The company reported a remarkable revenue of $8.8 million in the second quarter, marking a year-over-year increase of 95% and a sequential rise of 18%, indicating strong market traction. Additionally, Stereotaxis's successful regulatory advancements and ongoing product launches, particularly the MAGiC and MAGiC Sweep catheters, position the company for further leverage and increased revenue streams, with expectations for quarterly earnings to exceed $10 million in FY26.
Bears say
Stereotaxis Inc. reported operating expenses of $8.6 million, with adjusted expenses decreasing to $6 million, but still indicates significant cost pressures amid challenges in their operating environment. The company faces multiple risks, including delays in product approvals, supply chain issues, and increased competition, all of which could adversely affect revenue streams and impede growth. Additionally, Stereotaxis has a limited cash runway of two years, necessitating further financing, and is vulnerable to reimbursement rate reductions that may negatively impact its financial performance.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares